Medicines distributed by FBM

All FBM medicines are approved for use in Australia, and are subsequently required to meet the same strict regulations applied to the original brand, with regard to quality, safety and effectiveness.

Consumer Medicine Information (CMI)

Browse below for consumer medicine information (CMI)

Consumer Medicine Information or CMI, provides clear easy-to-understand information to consumers and their carers about how to use their medicines.

CMI leaflets for For Benefit Medicines products are included on this page. Importantly, this information does not replace advice from a health care professional.

You should discuss the CMI with your health care professional if you have any questions or concerns.


Anastrozole FBM

To view the full Consumer Medicine Information (CMI) please click HERE

For more information, please contact your doctor or pharmacist.


Letrozole FBM

To view the full Consumer Medicine Information (CMI) please click HERE

For more information, please contact your doctor or pharmacist.


Cipla Imatinib Adult

To view the full Consumer Medicine Information (CMI) please click HERE

For further information, please contact your doctor or pharmacist.


Tobramycin WKT.

To view the full Consumer Medicine Information (CMI), please click HERE

For further information, please contact your doctor or pharmacist.

For more information about generic medications, visit the Therapeutic Goods Administration (TGA) website here


FBM believes every cloud has a silver lining meaning that patients can help others with the same condition by using an FBM product. As such, cloud imagery features prominently on all FBM product packaging for ease of identification. 

By choosing an FBM product, you will be investing into local support programs today, and medical research for tomorrow. 

Click HERE to find out how you can support FBM.